We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDWR icon
901
Radware
RDWR
$1.19B
$1.12M 0.01%
44,284
+1,840
+4% +$42.8K
HTBK
902
DELISTED
Heritage Commerce
HTBK
$1.11M 0.01%
+65,348
New +$1.11M
GBCI icon
903
Glacier Bancorp
GBCI
$6.35B
$1.1M 0.01%
+28,529
New +$1.11M
APTX
904
DELISTED
Aptinyx Inc. Common Stock
APTX
$1.1M 0.01%
+45,556
New +$975K
PCOM
905
DELISTED
Points.com Inc. Common Shares
PCOM
$1.1M 0.01%
+66,779
New +$846K
GTS
906
DELISTED
Triple-S Management Corporation
GTS
$1.09M 0.01%
29,431
+15,858
+117% +$501K
BSM icon
907
Black Stone Minerals
BSM
$3B
$1.09M 0.01%
58,909
+44,477
+308% +$800K
TIER
908
DELISTED
TIER REIT, Inc.
TIER
$1.08M 0.01%
+45,378
New +$944K
CYBR
909
DELISTED
CyberArk
CYBR
$1.07M 0.01%
17,033
-109,580
-87% -$6.4M
UBA
910
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$1.07M 0.01%
+47,365
New +$992K
AGO icon
911
Assured Guaranty
AGO
$3.34B
$1.07M 0.01%
+29,823
New +$1.09M
LEN icon
912
Lennar Class A
LEN
$21.2B
$1.06M 0.01%
20,906
-56,436
-73% -$2.95M
TROW icon
913
T. Rowe Price
TROW
$24.3B
$1.06M 0.01%
9,132
+6,316
+224% +$734K
IMO icon
914
Imperial Oil
IMO
$60.4B
$1.06M 0.01%
+31,793
New +$994K
AGX icon
915
Argan
AGX
$8.37B
$1.05M 0.01%
25,744
-26,838
-51% -$1.05M
DRI icon
916
Darden Restaurants
DRI
$24.4B
$1.05M 0.01%
9,833
-47,772
-83% -$4.37M
SIOX
917
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.05M 0.01%
+58,082
New +$857K
WNC icon
918
Wabash National
WNC
$527M
$1.04M 0.01%
56,034
-418,383
-88% -$8.49M
PCRX icon
919
Pacira BioSciences
PCRX
$997M
$1.04M 0.01%
32,571
-36,747
-53% -$1.27M
NHI icon
920
National Health Investors
NHI
$3.65B
$1.03M 0.01%
+14,042
New +$992K
SRI icon
921
Stoneridge
SRI
$213M
$1.03M 0.01%
29,269
+4,919
+20% +$149K
STKL
922
DELISTED
SunOpta
STKL
$1.03M 0.01%
+122,380
New +$926K
CORT icon
923
Corcept Therapeutics
CORT
$12B
$1.02M 0.01%
65,012
-256,252
-80% -$4.46M
WBS icon
924
Webster Financial
WBS
$12.8B
$1.02M 0.01%
+16,043
New +$999K
CHS
925
DELISTED
Chicos FAS, Inc.
CHS
$1.02M 0.01%
125,366
-512,464
-80% -$4.85M
35 36
37
38 39

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.